These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35429101)

  • 21. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
    Hua S; Lei L; Deng L; Weng X; Liu C; Qi X; Wang S; Zhang D; Zou X; Cao C; Liu L; Wu D
    Oncogene; 2018 Mar; 37(12):1624-1636. PubMed ID: 29335523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Butein Inhibited In Vitro Hexokinase-2-Mediated Tumor Glycolysis in Hepatocellular Carcinoma by Blocking Epidermal Growth Factor Receptor (EGFR).
    Liao W; Liu J; Zhang D; Huang W; Chen R
    Med Sci Monit; 2018 May; 24():3283-3292. PubMed ID: 29777095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma.
    Feng J; Wu L; Ji J; Chen K; Yu Q; Zhang J; Chen J; Mao Y; Wang F; Dai W; Xu L; Wu J; Guo C
    J Exp Clin Cancer Res; 2019 May; 38(1):204. PubMed ID: 31101057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis.
    Feng J; Dai W; Mao Y; Wu L; Li J; Chen K; Yu Q; Kong R; Li S; Zhang J; Ji J; Wu J; Mo W; Xu X; Guo C
    J Exp Clin Cancer Res; 2020 Jan; 39(1):24. PubMed ID: 32000827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deoxyribonuclease 1-like 3 Inhibits Hepatocellular Carcinoma Progression by Inducing Apoptosis and Reprogramming Glucose Metabolism.
    Xiao Y; Yang K; Liu P; Ma D; Lei P; Liu Q
    Int J Biol Sci; 2022; 18(1):82-95. PubMed ID: 34975319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HuaChanSu suppresses tumor growth and interferes with glucose metabolism in hepatocellular carcinoma cells by restraining Hexokinase-2.
    Wu Q; Wang SP; Sun XX; Tao YF; Yuan XQ; Chen QM; Dai L; Li CL; Zhang JY; Yang AL
    Int J Biochem Cell Biol; 2022 Jan; 142():106123. PubMed ID: 34826616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma.
    Shen YC; Ou DL; Hsu C; Lin KL; Chang CY; Lin CY; Liu SH; Cheng AL
    Br J Cancer; 2013 Jan; 108(1):72-81. PubMed ID: 23257894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Astragalin Reduces Hexokinase 2 through Increasing miR-125b to Inhibit the Proliferation of Hepatocellular Carcinoma Cells in Vitro and in Vivo.
    Li W; Hao J; Zhang L; Cheng Z; Deng X; Shu G
    J Agric Food Chem; 2017 Jul; 65(29):5961-5972. PubMed ID: 28654261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA HOTAIR knockdown inhibits glycolysis by regulating miR-130a-3p/HIF1A in hepatocellular carcinoma under hypoxia.
    Hu M; Fu Q; Jing C; Zhang X; Qin T; Pan Y
    Biomed Pharmacother; 2020 May; 125():109703. PubMed ID: 32062551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. USP29-mediated HIF1α stabilization is associated with Sorafenib resistance of hepatocellular carcinoma cells by upregulating glycolysis.
    Gao R; Buechel D; Kalathur RKR; Morini MF; Coto-Llerena M; Ercan C; Piscuoglio S; Chen Q; Blumer T; Wang X; Dazert E; Heim MH; Hall MN; Tang F; Christofori G
    Oncogenesis; 2021 Jul; 10(7):52. PubMed ID: 34272356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. β-HB treatment reverses sorafenib resistance by shifting glycolysis-lactate metabolism in HCC.
    Suk FM; Wu CY; Fang CC; Chen TL; Liao YJ
    Biomed Pharmacother; 2023 Oct; 166():115293. PubMed ID: 37567069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
    Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D
    Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CircCDKN2B-AS1 interacts with IMP3 to stabilize hexokinase 2 mRNA and facilitate cervical squamous cell carcinoma aerobic glycolysis progression.
    Zhang Y; Zhao L; Yang S; Cen Y; Zhu T; Wang L; Xia L; Liu Y; Zou J; Xu J; Li Y; Cheng X; Lu W; Wang X; Xie X
    J Exp Clin Cancer Res; 2020 Dec; 39(1):281. PubMed ID: 33308298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbiota-derived SSL6 enhances the sensitivity of hepatocellular carcinoma to sorafenib by down-regulating glycolysis.
    Zhang X; Wu L; Xu Y; Yu H; Chen Y; Zhao H; Lei J; Zhou Y; Zhang J; Wang J; Peng J; Jiang L; Sheng H; Li Y
    Cancer Lett; 2020 Jul; 481():32-44. PubMed ID: 32246956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-3662 suppresses cell growth, invasion and glucose metabolism by targeting HK2 in hepatocellular carcinoma cells.
    Ye J; Xiao X; Han Y; Fan D; Zhu Y; Yang L
    Neoplasma; 2020 Jul; 67(4):773-781. PubMed ID: 32726127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of miR-199a maturation by HuR is crucial for hypoxia-induced glycolytic switch in hepatocellular carcinoma.
    Zhang LF; Lou JT; Lu MH; Gao C; Zhao S; Li B; Liang S; Li Y; Li D; Liu MF
    EMBO J; 2015 Nov; 34(21):2671-85. PubMed ID: 26346275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment.
    Cassim S; Raymond VA; Dehbidi-Assadzadeh L; Lapierre P; Bilodeau M
    Cell Cycle; 2018; 17(7):903-916. PubMed ID: 29633904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC.
    Yin Y; Sun M; Zhan X; Wu C; Geng P; Sun X; Wu Y; Zhang S; Qin J; Zhuang Z; Liu Y
    J Exp Clin Cancer Res; 2019 Feb; 38(1):83. PubMed ID: 30770740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma.
    Weng Q; Chen M; Yang W; Li J; Fan K; Xu M; Weng W; Lv X; Fang S; Zheng L; Song J; Zhao Z; Fan X; Ji J
    FASEB J; 2020 Apr; 34(4):5420-5434. PubMed ID: 32080912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EGR1 suppresses HCC growth and aerobic glycolysis by transcriptionally downregulating PFKL.
    Pan M; Luo M; Liu L; Chen Y; Cheng Z; Wang K; Huang L; Tang N; Qiu J; Huang A; Xia J
    J Exp Clin Cancer Res; 2024 Jan; 43(1):35. PubMed ID: 38287371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.